Connection

Elizabeth Garrett-Mayer to HL-60 Cells

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about HL-60 Cells.
Elizabeth Garrett-Mayer
Connection Strength
0.020
HL-60 Cells
  1. Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide. Blood. 2009 May 14; 113(20):4841-52.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.